AMMA MEDICAL LIMITEDActive

Company number 08372885Private limited companyIncorporated 2013

Key figures

£512,400+26.3%
Net assets 2024/25
+31.5%
Average annual growth 2020/21–2024/25
0200 k400 k600 k2020/212021/222022/232023/242024/25

Like most small UK companies, AMMA MEDICAL LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand212,610274,641165,73635,90660,989
Total assets217,161278,578373,939445,526561,946
Total liabilities45,81347,84860,40939,83249,546
Net assets / total equity171,348230,730313,530405,694512,400
Average number of employees22222

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: AMMA MEDICAL LIMITED

Company

AMMA MEDICAL LIMITED is a private limited company registered with Companies House under company number 08372885. It was incorporated on 24 Jan 2013. Its status is active. The registered office is in Newcastle under lyme (ST5). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Jan 2025); the company files small company accounts (filleted). Net assets were £512,400, up 26.3% on the previous year. Cash at bank and in hand was £60,989. Total assets were £561,946 and total liabilities £49,546. The company had an average of 2 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Oct 2026. The next confirmation statement is due by 18 Feb 2027.